Blood Purification Technologies

Blood Purification Technologies is a medical device company focused on developing the Wearable Artificial Kidney (WAK), an innovative portable dialysis system designed to improve quality of life for patients with end-stage renal disease. In February 2014, the company received FDA approval to begin the first human clinical trials in the United States for this device. The WAK won an FDA Innovation award and was developed under the leadership of Dr. Victor Gura at Cedars Sinai Hospital and UCLA. The WAK aims to provide continuous ambulatory blood purification, potentially reducing costs and improving outcomes compared to traditional stationary dialysis.